AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES.

This bill creates a new advisory council to oversee the development and delivery of chimeric antigen receptor T-cell therapy and other gene therapies for cancer treatment within the state. The council will advise the Department of Public Health on issues such as patient access, safety protocols, training for medical providers, and equitable distribution of care across different communities. It will be composed of 22 members including state officials, medical experts, patient advocates, and representatives from healthcare organizations, with appointments beginning by October 2026. The council will hold public hearings, research best practices, and work to establish centers of excellence and a statewide referral network to ensure all eligible patients can receive these advanced treatments.